Advertisement

Temporary Use of the Jarvik-7 Artificial Heart — The Pittsburgh Experience

  • B. P. Griffith
Conference paper

Abstract

Nearly concurrently with the development of the pneumatic artificial heart [1, 2], cardiac transplantation emerged from an experimental to a therapeutic procedure [3]. By 1987, the International Cardiac Transplant Registry had 4600 entries, and current 1-year expectation for survival exceeds 80% [4]. The increased use of cardiac transplantation has prolonged the waiting period even for those patients who are most critically ill - from less than 5 days in 1980, when cardiac transplantation was performed in five centers in the United States, to more than 42 days in 1986, when the procedure was performed in more than 60 centers [3]. Our group has previously shown that there is a group of mortally ill patients who might survive if their circulation could be temporarily and safely supported by an intravenous, inotropic system and the intra-aortic balloon pump (IABP) [5].

Keywords

Cardiac Transplantation Artificial Heart Donor Heart Lethal Infection Total Artificial Heart 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Working Group on Mechanical Circulatory Support of the National Heart, Lung, and Blood Institute (1985) Artificial heart and assist devices: directions, needs, costs, societal, and ethical issues. National Heart, Lung, and Blood Institute, Bethesda, May 1985Google Scholar
  2. 2.
    DeVries WC, Anderson JL, Joyce LD et al. (1984) Clinical use of the total artificial heart. N Engl J Med 310:273–278PubMedCrossRefGoogle Scholar
  3. 3.
    Griffith BP, Hardestry RL, Trento A et al. (1986) Cardiac transplantation: emerging from an experiment to a service. Ann Surg 204:308–314PubMedCrossRefGoogle Scholar
  4. 4.
    Kaye MP (1987) The registry of the International Society for Heart Transplantation: fourth official report - 1987. Heart Transplant 6:63–67Google Scholar
  5. 5.
    Hardesty RL, Griffith BP, Trento A et al. (1986) Mortally ill patients and excellent survival following cardiac transplantation. Ann Thorac Surg 41:126–129PubMedCrossRefGoogle Scholar
  6. 6.
    Trento A, Hardesty RL, Griffith BP et al. (1988) Role of the antibidoy to vascular endothelial cells in hyperacute rejection in patients undergoing cardiac transplantation. J Thorac Cardiovasc Surg 95:37–41PubMedGoogle Scholar
  7. 7.
    Griffith BP, Kormos RL, Hardesty RL et al. (1988) The artificial heart: infection-related morbidity and its effect on transplantation. Ann Thorac Surg 45(4):409–415PubMedCrossRefGoogle Scholar
  8. 8.
    Annas GJ (1985) No cheers for temporary artificial hearts. Hastings Cent Rep 15:27–28PubMedGoogle Scholar
  9. 9.
    Griffith BP, Bahnson HT, Roth LH (1987) Rebuttal to George J. Annas’ letter to the editor. N Engl J Med 317:315CrossRefGoogle Scholar
  10. 10.
    Reiman AS (1986) Artificial hearts - permanent and temporary. N Engl J Med 314:644–645CrossRefGoogle Scholar
  11. 11.
    Griffith BP, Hardesty RL, Kormos RL et al. (1987) Temporary use of the Jarvik-7 total artificial heart prior to transplantation. N Engl J Med 316:130–134PubMedCrossRefGoogle Scholar
  12. 12.
    Cabrol CE, Gandjbakhch I, Pavie A et al. (1988) Orthotopic heart transplantation survival after total artificial heart implantation. Presented at the annual meeting, Am Assn Thorac Surg, Los AngelesGoogle Scholar
  13. 13.
    DeVries WC (1988) The permanent artificial heart, four case reports. JAMA 259:849–859PubMedCrossRefGoogle Scholar
  14. 14.
    Kunin CM, Dobbins JJ, Melo LG et al. (1988) Infectious complications in four long-term recipients of the Jarvik-7 artificial heart. JAMA 259:860–869PubMedCrossRefGoogle Scholar
  15. 15.
    Gristina AG, Dobbins JJ, Grammara B et al. (1988) Biomaterial-centered sepsis and the total artificial heart, microbial adhesions vs tissue integration. JAMA 259:870–874PubMedCrossRefGoogle Scholar
  16. 16.
    Farrar DJ, Hill D, Gray LA et al. (1988) Heterotopic prosthetic ventricles as a bridge to cardiac transplantation. N Engl J Med 318:333–340PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • B. P. Griffith

There are no affiliations available

Personalised recommendations